Literature DB >> 28429802

Parkinson disease: In situ astrocyte reprogramming - simpler cell replacement therapy in PD?

Ian Fyfe.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28429802     DOI： 10.1038/nrneurol.2017.60

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.

Authors:  Pia Rivetti di Val Cervo; Roman A Romanov; Giada Spigolon; Débora Masini; Elisa Martín-Montañez; Enrique M Toledo; Gioele La Manno; Michael Feyder; Christian Pifl; Yi-Han Ng; Sara Padrell Sánchez; Sten Linnarsson; Marius Wernig; Tibor Harkany; Gilberto Fisone; Ernest Arenas
Journal:  Nat Biotechnol       Date:  2017-04-10       Impact factor: 54.908
  1 in total
  2 in total

1.  Advances in Transcription Factors Related to Neuroglial Cell Reprogramming.

Authors:  Kuangpin Liu; Wei Ma; Chunyan Li; Junjun Li; Xingkui Zhang; Jie Liu; Wei Liu; Zheng Wu; Chenghao Zang; Yu Liang; Jianhui Guo; Liyan Li
Journal:  Transl Neurosci       Date:  2020-02-20       Impact factor: 1.757

2.  Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences.

Authors:  Ya-Fei Zhao; Da-Neng Wei; Yong Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.